Catalyst Pharmaceuticals CEO and leadership

Patrick McEnany is a Chairman/CEO at CATALYST PHARMACEUTICALS, INC..

Gary Ingenito is a Chief Medical & Regulatory Officer at CATALYST PHARMACEUTICALS, INC. and is based in Boca Raton, Florida. He has worked as Chief Medical Officer & Head of Regulatory at CATALYST PHARMACEUTICALS, INC.; Senior Vice President at Seaboard Folding Box Company, Inc.; and Senior VP:Scientific Affairs at CATASYS, INC.. Gary attended Johns Hopkins University and Thomas Jefferson University Hospital.

Jeff Carmen is a Chief Commercial Officer at CATALYST PHARMACEUTICALS, INC. and is based in Coral Gables, Florida. He has worked as Neuroscience Product Manager at Abbott, Dyslipidemia Product Manager at Abbott, and Senior District Sales Manager at Abbott. Jeff works or has worked as Senior Dir:Rare Disease Marketing at Complete Pharma Holdings LLC and VP:Sales at INSYS THERAPEUTICS INC. He attended University of Wisconsin-Madison between 2009 and 2011 and University of Dayton between 1988 and 1992.

Steven R. Miller, Ph.D., is responsible for Catalyst’s product development program, which includes all aspects of chemistry and manufacturing controls, quality systems, contract operations, and development planning. Dr. Miller has 25 years of experience in the pharmaceutical and healthcare industries, joining Catalyst in 2007. Most recently he has managed Catalyst's efforts in identifying, due diligence, and ultimate in-licensing of CPP-115 and Catalyst's newest drug, Firdapse™, and taking these products through various preclinical and clinical development studies. Dr. Miller previously served as Executive Director for Research and Development Operations at Watson Pharmaceuticals and as Vice President of Research and Product Development at Royce Laboratories; he has also managed medical device development groups at Baxter Diagnostics and worked as an analytical chemist for the U.S. Food and Drug Administration. Dr. Miller received his doctorate in physical organic chemistry at the University of Miami; his work has been published in numerous technical and professional journals including Journal of Analytical Chemistry, Journal of the American Chemical Society, Journal of Medicinal Chemistry, and Chemical Communications.

Brian Elsbernd is a CLO/Chief Compliance Officer at CATALYST PHARMACEUTICALS, INC.. He has worked as Senior VP:Legal & Compliance at CATALYST PHARMACEUTICALS, INC.. Brian works or has worked as Senior Dir: US Healthcare Compliance at Mallinckrodt Brand Pharmaceuticals Inc, Associate at Proskauer Rose LLP, and Senior Director:US Health Care at Mallinckrodt Pharmaceuticals Ltd. He studied at SLU LAW and University of Illinois.

Patrick McEnany is a Chairman/CEO at CATALYST PHARMACEUTICALS, INC..

Patrick McEnany is a Chairman/CEO at CATALYST PHARMACEUTICALS, INC..